title: Therapeutic epilepsy research: from pharmacological rationale to focal adenosine augmentation.
abstract: Epilepsy is a common seizure disorder affecting approximately 70 million people worldwide. Current pharmacotherapy is neuron-centered, frequently accompanied by intolerable side effects, and fails to be effective in about one third of patients. Therefore, new therapeutic concepts are needed. Recent research suggests an astrocytic basis of epilepsy, presenting the possibility of novel therapeutic targets. In particular, dysfunction of the astrocyte-controlled, endogenous, adenosine-based seizure control system of the brain is implicated in seizure generation. Thus, astrogliosis - a pathological hallmark of the epileptic brain - is associated with upregulation of the adenosine-removing enzyme adenosine kinase (ADK), resulting in focal adenosine deficiency. Both astrogliotic upregulation of ADK in epilepsy and transgenic overexpression of ADK are associated with seizures, and inhibition of ADK prevents seizures in a mouse model of pharmacoresistant epilepsy. These findings link adenosine deficiency with seizures and predict that adenosine augmentation therapies (AATs) will likely be effective in preventing seizures. Given the wide-spread systemic and central side effects of systemically administered AATs, focal AATs (i.e., limited to the astrogliotic lesion) are a necessity. This Commentary will discuss the pharmacological rationale for the development of focal AATs. Additionally, several AAT strategies will be discussed: (1) adenosine released from silk-based brain implants; (2) adenosine released from locally implanted encapsulated cells; (3) adenosine released from stem cell-derived brain implants; and (4) adenosine augmenting gene therapies. Finally, new developments and therapeutic challenges in using focal AATs for epilepsy therapy will critically be evaluated.
authors.affiliation: Robert Stone Dow Neurobiology Laboratories, Legacy Research, Portland, OR 97232, USA. dboison@downeurobiology.org
authors.forename: Detlev
authors.initials: D
authors.lastname: Boison
authors.forename: Kerry-Ann
authors.initials: KA
authors.lastname: Stewart
mesh_terms: D000241:Adenosine / Q000008:administration & dosage / Q000494:pharmacology / Q000502:physiology*; D000248:Adenosine Kinase / Q000187:drug effects; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use*; D001253:Astrocytes / Q000187:drug effects; D001921:Brain / Q000166:cytology / Q000187:drug effects; D016503:Drug Delivery Systems; D004343:Drug Implants; D004827:Epilepsy / Q000188:drug therapy* / Q000628:therapy; D015316:Genetic Therapy; D006801:Humans; D051379:Mice; D009457:Neuroglia / Q000187:drug effects; D051381:Rats; D013234:Stem Cells / Q000502:physiology
chemical_list: D000927:Anticonvulsants; D004343:Drug Implants; D000248:Adenosine Kinase; D000241:Adenosine
references.citation: Prog Brain Res. 1999;120:93-106
references.pmid: 10550990
references.citation: Expert Opin Investig Drugs. 2000 Mar;9(3):551-64
references.pmid: 11060695
references.citation: Science. 2005 Oct 7;310(5745):113-6
references.pmid: 16210541
references.citation: Nat Rev Drug Discov. 2008 Jul;7(7):575-90
references.pmid: 18591979
references.citation: Nat Rev Drug Discov. 2006 Mar;5(3):247-64
references.pmid: 16518376
references.citation: Exp Neurol. 1991 Mar;111(3):269-75
references.pmid: 1999230
references.citation: Adv Myocardiol. 1985;6:273-84
references.pmid: 2986260
references.citation: Neuroscientist. 2005 Feb;11(1):25-36
references.pmid: 15632276
references.citation: J Neurosci. 2004 Jan 21;24(3):692-701
references.pmid: 14736855
references.citation: Neurology. 2005 Jun 28;64(12 Suppl 3):S2-11
references.pmid: 15994220
references.citation: Mol Ther. 2003 Apr;7(4):506-14
references.pmid: 12727114
references.citation: J Cereb Blood Flow Metab. 2006 Apr;26(4):565-75
references.pmid: 16121125
references.citation: Neurosci Lett. 2004 Nov 11;370(2-3):160-5
references.pmid: 15488315
references.citation: Pharmacol Rev. 2001 Dec;53(4):527-52
references.pmid: 11734617
references.citation: Prog Neurobiol. 2008 Mar;84(3):249-62
references.pmid: 18249058
references.citation: Trends Neurosci. 2008 Jun;31(6):273-8
references.pmid: 18471903
references.citation: Neurotherapeutics. 2009 Apr;6(2):218-27
references.pmid: 19332313
references.citation: Biochem J. 1978 Sep 15;174(3):965-77
references.pmid: 215126
references.citation: Exp Neurol. 2006 Jul;200(1):184-90
references.pmid: 16750195
references.citation: Ann Neurol. 1992 Nov;32(5):618-24
references.pmid: 1449242
references.citation: Glia. 2004 Aug 15;47(3):226-32
references.pmid: 15252811
references.citation: Exp Neurol. 2004 Dec;190(2):544-7
references.pmid: 15530893
references.citation: Neurobiol Dis. 2008 Jan;29(1):142-60
references.pmid: 17931873
references.citation: Neuron Glia Biol. 2007 Nov;3(4):353-66
references.pmid: 18634566
references.citation: Nat Med. 2005 Sep;11(9):973-81
references.pmid: 16116433
references.citation: Lancet. 2007 Jun 23;369(9579):2097-105
references.pmid: 17586305
references.citation: Exp Neurol. 2007 Nov;208(1):26-37
references.pmid: 17716659
references.citation: Epilepsia. 2008 Oct;49(10):1651-64
references.pmid: 18503563
references.citation: Neurol Res. 2008 Nov;30(9):920-5
references.pmid: 18593522
references.citation: Neurotherapeutics. 2009 Apr;6(2):300-6
references.pmid: 19332323
references.citation: Curr Neuropharmacol. 2007;5(2):115-25
references.pmid: 18615179
references.citation: Curr Pharm Des. 2008;14(15):1525-52
references.pmid: 18537675
references.citation: J Clin Invest. 2008 Feb;118(2):571-82
references.pmid: 18172552
references.citation: Trends Neurosci. 2008 Feb;31(2):62-73
references.pmid: 18201772
references.citation: Epilepsia. 2009 Feb;50(2):322-5
references.pmid: 18717710
references.citation: Annu Rev Nutr. 2008;28:273-93
references.pmid: 18331185
references.citation: Br J Pharmacol. 2001 Apr;132(7):1615-23
references.pmid: 11264257
references.citation: Exp Neurol. 2009 Sep;219(1):126-35
references.pmid: 19460372
references.citation: Lancet Neurol. 2008 May;7(5):400-8
references.pmid: 18387850
references.citation: Pflugers Arch. 1980 Sep;387(3):245-51
references.pmid: 6253877
references.citation: J Neurosci. 2008 Mar 26;28(13):3264-76
references.pmid: 18367594
references.citation: Physiol Rev. 2006 Jul;86(3):1009-31
references.pmid: 16816144
references.citation: Epilepsy Res. 2009 Apr;84(2-3):238-41
references.pmid: 19217263
references.citation: Acta Physiol (Oxf). 2009 Jan;195(1):111-22
references.pmid: 18983447
references.citation: Gene. 1989 Aug 1;80(1):137-44
references.pmid: 2551779
references.citation: Epilepsia. 1997 Jul;38(7):759-66
references.pmid: 9579902
references.citation: Brain. 2007 May;130(Pt 5):1276-88
references.pmid: 17472985
references.citation: Trends Neurosci. 2008 Mar;31(3):146-53
references.pmid: 18255164
references.citation: Exp Neurol. 1984 Jun;84(3):654-65
references.pmid: 6723886
references.citation: J Pharmacol Exp Ther. 2000 Dec;295(3):1156-64
references.pmid: 11082453
references.citation: Stem Cells. 2007 Oct;25(10):2396-407
references.pmid: 17600108
references.citation: Pflugers Arch. 2006 Aug;452(5):479-85
references.pmid: 16688467
references.citation: Trends Neurosci. 2007 Oct;30(10):527-35
references.pmid: 17904651
references.citation: Science. 2008 Dec 5;322(5907):1551-5
references.pmid: 19056987
references.citation: Epilepsia. 2003 Jul;44(7):877-85
references.pmid: 12823569
references.citation: Biomaterials. 2005 Jun;26(17):3385-93
references.pmid: 15621227
references.citation: J Pharmacol Exp Ther. 2000 Dec;295(3):1165-74
references.pmid: 11082454
references.citation: Trends Mol Med. 2007 Feb;13(2):54-63
references.pmid: 17207662
references.citation: Neuropharmacology. 2008 Dec;55(8):1364-75
references.pmid: 18824002
references.citation: Arzneimittelforschung. 1994 Dec;44(12):1305-12
references.pmid: 7848348
references.citation: Neurochem Int. 2008 Jan;52(1-2):65-72
references.pmid: 17664029
references.citation: Pharmacol Biochem Behav. 2002 Oct;73(3):573-81
references.pmid: 12151032
references.citation: Neurology. 2008 Jan 15;70(3):231-6
references.pmid: 18195269
references.citation: Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7611-6
references.pmid: 11404469
references.citation: Biochem Pharmacol. 2000 May 15;59(10):1173-85
references.pmid: 10736418
references.citation: Ann Neurol. 1991 Apr;29(4):356-63
references.pmid: 1929206
references.citation: Anesthesiology. 2002 Jan;96(1):24-8
references.pmid: 11752997
references.citation: Biomaterials. 2008 Sep;29(26):3609-16
references.pmid: 18514814
references.citation: Proc Natl Acad Sci U S A. 2002 May 14;99(10):6985-90
references.pmid: 11997462
references.citation: Curr Top Med Chem. 2005;5(1):43-58
references.pmid: 15638777
references.citation: Neuron. 2008 Apr 24;58(2):168-78
references.pmid: 18439402
references.citation: Exp Neurol. 2005 May;193(1):53-64
references.pmid: 15817264